Browse > Article
http://dx.doi.org/10.4070/kcj.2016.46.2.117

Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves  

Finsterer, Josef (Krankenanstalt Rudolfstiftung)
Stollberger, Claudia (2nd Medical Department with Cardiology and Intensive Care Medicine, Krankenanstalt Rudolfstiftung)
Publication Information
Korean Circulation Journal / v.46, no.2, 2016 , pp. 117-134 More about this Journal
Abstract
Little is known regarding cardiac involvement (CI) by neuromuscular disorders (NMDs). The purpose of this review is to summarise and discuss the major findings concerning the types, frequency, and severity of cardiac disorders in NMDs as well as their diagnosis, treatment, and overall outcome. CI in NMDs is characterized by pathologic involvement of the myocardium or cardiac conduction system. Less commonly, additional critical anatomic structures, such as the valves, coronary arteries, endocardium, pericardium, and even the aortic root may be involved. Involvement of the myocardium manifests most frequently as hypertrophic or dilated cardiomyopathy and less frequently as restrictive cardiomyopathy, non-compaction, arrhythmogenic right-ventricular dysplasia, or Takotsubo-syndrome. Cardiac conduction defects and supraventricular and ventricular arrhythmias are common cardiac manifestations of NMDs. Arrhythmias may evolve into life-threatening ventricular tachycardias, asystole, or even sudden cardiac death. CI is common and carries great prognostic significance on the outcome of dystrophinopathies, laminopathies, desminopathies, nemaline myopathy, myotonias, metabolic myopathies, Danon disease, and Barth-syndrome. The diagnosis and treatment of CI in NMDs follows established guidelines for the management of cardiac disease, but cardiotoxic medications should be avoided. CI in NMDs is relatively common and requires complete work-up following the establishment of a neurological diagnosis. Appropriate cardiac treatment significantly improves the overall long-term outcome of NMDs.
Keywords
Muscular diseases; Neuromuscular disease; Cardiomyopathies; Cardiac arrhythmias;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Namazi MH, Khaheshi I, Haybar H, Esmaeeli S. Cardiac failure as an unusual presentation in a patient with history of amyotrophic lateral sclerosis. Case Rep Neurol Med 2014;2014:986139.
2 Tanaka Y, Yamada M, Koumura A, et al. Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] MIBG scintigraphy. J Neurol 2013;260:2380-6.   DOI
3 Shemisa K, Kaelber D, Parikh SA, Mackall JA. Autonomic etiology of heart block in amyotrophic lateral sclerosis: a case report. J Med Case Rep 2014;8:224.   DOI
4 Massari FM, Tonella T, Tarsia P, Kirani S, Blasi F, Magrini F. Tako-tsubo syndrome in a young man with amyotrophic lateral sclerosis. A case report. G Ital Cardiol (Rome) 2011;12:388-91.
5 Araki A, Katsuno M, Suzuki K, et al. Brugada syndrome in spinal and bulbar muscular atrophy. Neurology 2014 20;82:1813-21.   DOI
6 Sakpichaisakul K, Taeranawich P, Nitiapinyasakul A, Sirisopikun T. Identification of Sandhoff disease in a Thai family: clinical and biochemical characterization. J Med Assoc Thai 2010;93:1088-92.
7 Carr AS, Pelayo-Negro AL, Jaunmuktane Z, et al. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy. Neuromuscul Disord 2015;25:511-5.   DOI
8 Longhi S, Quarta CC, Milandri A, et al. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid 2015; 22:147-55.   DOI
9 Klein CJ, Wu Y, Vogel P, et al. Ubiquitin ligase defect by DCAF8 mutation causes HMSN2 with giant axons. Neurology 2014;82:873-8.   DOI
10 Sacconi S, Wahbi K, Theodore G, et al. Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease. Neuromuscul Disord 2014;24:648-50.   DOI
11 Mogahed EA, Girgis MY, Sobhy R, Elhabashy H, Abdelaziz OM, El-Karaksy H. Skeletal and cardiac muscle involvement in children with glycogen storage disease type III. Eur J Pediatr 2015;174:1545-8.   DOI
12 Sentner CP, Caliskan K, Vletter WB, Smit GP. Heart failure due to severe hypertrophic cardiomyopathy reversed by low calorie, high protein dietary adjustments in a glycogen storage disease type IIIa patient. JIMD Rep 2012;5:13-6.
13 Marques J, Duarte ST, Costa S, et al. Atypical phenotype in two patients with LAMA2 mutations. Neuromuscul Disord 2014;24:419-24.   DOI
14 Austin SL, Proia AD, Spencer-Manzon MJ, Butany J, Wechsler SB, Kishnani PS. Cardiac pathology in glycogen storage disease type III. JIMD Rep 2012;6:65-72.
15 LaBarbera M, Milechman G, Dulbecco F. Premature coronary artery disease in a patient with glycogen storage disease III. J Invasive Cardiol 2010;22:E156-8.
16 Magoulas PL, El-Hattab AW. Glycogen Storage Disease Type IV. 2013 Jan 03. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews$^{(R)}$ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from http://www.ncbi.nlm.nih.gov/books/NBK115333/.
17 Moustafa S, Patton DJ, Connelly MS. Unforeseen cardiac involvement in McArdle's disease. Heart Lung Circ 2013;22:769-71.   DOI
18 Amit R, Bashan N, Abarbanel JM, Shapira Y, Sofer S, Moses S. Fatal familial infantile glycogen storage disease: multisystem phosphofructokinase deficiency. Muscle Nerve 1992;15:455-8.   DOI
19 Schoser B, Bruno C, Schneider HC, et al. Unclassified polysaccharidosis of the heart and skeletal muscle in siblings. Mol Genet Metab 2008;95:52-8.   DOI
20 Carboni N, Marrosu G, Porcu M, et al. Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-${\alpha}2$-chain gene: a chance association or a novel phenotype? Muscle Nerve 2011;44:826-8.   DOI
21 Matsuda H, Arai M, Okamoto H. Total intravenous anesthesia for a patient with Fukuyama congenital muscular dystrophy undergoing scoliosis surgery. Masui 2014;63:650-3.
22 Pane M, Messina S, Vasco G, et al. Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency. Neuromuscul Disord 2012;22:685-9.   DOI
23 Ceviz N, Alehan F, Alehan D, et al. Assessment of left ventricular systolic and diastolic functions in children with merosin-positive congenital muscular dystrophy. Int J Cardiol 2003;87:129-33; discussion 133-4.   DOI
24 Vattemi G, Neri M, Piffer S, et al. Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. Acta Myol 2011;30:121-6.
25 Konersman CG, Bordini BJ, Scharer G, et al. BAG3 myofibrillar myopathy presenting with cardiomyopathy. Neuromuscul Disord 2015;25:418-22.   DOI
26 Lee HC, Cherk SW, Chan SK, et al. BAG3-related myofibrillar myopathy in a Chinese family. Clin Genet 2012;81:394-8.   DOI
27 Liewluck T, Kintarak J, Sangruchi T, Selcen D, Kulkantrakorn K. Myofibrillar myopathy with limb-girdle phenotype in a Thai patient. J Med Assoc Thai 2009;92:290-5.
28 Pinol-Ripoll G, Shatunov A, Cabello A, et al. Severe infantile-onset cardiomyopathy associated with a homozygous deletion in desmin. Neuromuscul Disord 2009;19:418-22.   DOI
29 Corrado G, Checcarelli N, Santarone M, Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot-Marie-Tooth disease type 1A. Cardiology 2006;105:142-5.   DOI
30 Uechi Y, Higa K. Recurrent takotsubo cardiomyopathy within a short span of time in a patient with hereditary motor and sensory neuropathy. Intern Med 2008;47:1609-13.   DOI
31 Hofstad H, Ohm OJ, Mork SJ, Aarli JA. Heart disease in myasthenia gravis. Acta Neurol Scand 1984;70:176-84.
32 Tanahashi N, Sato H, Nogawa S, Satoh T, Kawamura M, Shimoda M. A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis. Keio J Med 2004;53:30-42.
33 Thanaviratananich S, Katirji B, Alshekhlee A. Broken heart syndrome during myasthenic crisis. J Clin Neuromuscul Dis 2014;15:90-5.   DOI
34 Mayor-Gomez S, Lacruz F, Ezpeleta D. Myasthenic crisis and Takotsubo syndrome: a non-chance relationship. Rev Neurol 2012;55:725-8.
35 Bansal V, Kansal MM, Rowin J. Broken heart syndrome in myasthenia gravis. Muscle Nerve 2011;44:990-3.   DOI
36 Beydoun SR, Wang J, Levine RL, Farvid A. Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report. J Med Case Rep 2010;4:393.   DOI
37 Ojala T, Nupponen I, Saloranta C, et al. Fetal left ventricular noncompaction cardiomyopathy and fatal outcome due to complete deficiency of mitochondrial trifunctional protein. Eur J Pediatr 2015;174:1689-92.   DOI
38 Lang SM, Shugh S, Mazur W, et al. Myocardial fibrosis and left ventricular dysfunction in Duchenne muscular dystrophy carriers using cardiac magnetic resonance imaging. Pediatr Cardiol 2015;36:1495-501.   DOI
39 Brunklaus A, Parish E, Muntoni F, et al. The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol 2015;19:395-401.   DOI
40 Baruteau J, Sachs P, Broue P, et al. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis 2013;36:795-803.   DOI
41 Zhang RN, Li YF, Qiu WJ, et al. Clinical features and mutations in seven Chinese patients with very long chain acyl-CoA dehydrogenase deficiency. World J Pediatr 2014;10:119-25.   DOI
42 Eminoglu TF, Tumer L, Okur I, Ezgu FS, Biberoglu G, Hasanoglu A. Very long-chain acyl CoA dehydrogenase deficiency which was accepted as infanticide. Forensic Sci Int 2011;210:e1-3.   DOI
43 Missaglia S, Tasca E, Angelini C, Moro L, Tavian D. Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings. Mol Genet Metab 2015;115:110-7.   DOI
44 Kaneko K, Kuroda H, Izumi R, et al. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review. Neuromuscul Disord 2014;24:634-41.   DOI
45 Iacobazzi V, Invernizzi F, Baratta S, et al. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency. Hum Mutat 2004;24:312-20.   DOI
46 Yilmaz BS, Kor D, Mungan NO, Erdem S, Ceylaner S. Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up. J Pediatr Endocrinol Metab 2015;28:1179-81.
47 Chauveau C, Bonnemann CG, Julien C, et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum Mol Genet 2014;23:980-91.   DOI
48 Zheng M, Cheng H, Li X, et al. Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum Mol Genet 2009;18:701-13.   DOI
49 Stollberger C, Gatterer E, Finsterer J, Kuck KH, Tilz RR. Repeated radiofrequency ablation of atrial tachycardia in restrictive cardiomyopathy secondary to myofibrillar myopathy. J Cardiovasc Electrophysiol 2014;25:905-7.   DOI
50 El-Menyar AA, Al-Suwaidi J, Gehani AA, Bener A. Clinical and histologic studies of a Qatari family with myofibrillar myopathy. Saudi Med J 2004;25:1723-6.
51 Simsek Z, Acar G, Akcakoyun M, Esen O, Emiroglu Y, Esen AM. Left ventricular noncompaction in a patient with multiminicore disease. J Cardiovasc Med (Hagerstown) 2012;13:660-2.   DOI
52 Cullup T, Lamont PJ, Cirak S, et al. Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement. Neuromuscul Disord 2012;22:1096-104.   DOI
53 Hachenberg T, Brussel T, Lawin P, Konertz W, Scheld HH. Heart transplantation in a patient with central core disease. J Cardiothorac Vasc Anesth 1992;6:386-7.   DOI
54 Gal A, Inczedy-Farkas G, Pal E, et al. The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy. Clin Neuropathol 2015;34:89-95.   DOI
55 Al-Ruwaishid A, Vajsar J, Tein I, Benson L, Jay V. Centronuclear myopathy and cardiomyopathy requiring heart transplant. Brain Dev 2003;25:62-6.   DOI
56 Hikita T, Wakita S, Mori Y, et al. Severe infantile myotubular myopathy with complete atrioventricular block. Pediatr Int 2008;50:698-700.   DOI
57 Birnkrant DJ, Ararat E, Mhanna MJ. Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol 2015. [Epub ahead of print]
58 Tandon A, Villa CR, Hor KN, et al. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. J Am Heart Assoc 2015;4. pii:e001338.
59 Finsterer J, Gelpi E, Stollberger C. Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation. Acta Cardiol 2005;60:445-8.   DOI
60 Florian A, Rosch S, Bietenbeck M, et al. Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 2015. [Epub ahead of print]
61 Vidal-Perez R, Diaz-Villanueva J, Arzanauskaite M, Rojas R, Carreras F. Cardiac involvement in Becker muscular dystrophy: role of cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging 2013;14:1038.   DOI
62 Andrikopoulos G, Kourouklis S, Trika C, et al. Cardiac resynchronization therapy in becker muscular dystrophy. Hellenic J Cardiol 2013;54:227-9.
63 Tsuda T, Fitzgerald K, Scavena M, et al. Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27. J Hum Genet 2015;60:151-5.   DOI
64 Guo X, Dai Y, Cui L, Fang Q. A novel dystrophin deletion mutation in a becker muscular dystrophy patient with early-onset dilated cardiomyopathy. Can J Cardiol 2014;30:956.e1-3.   DOI
65 Petri H, Sveen ML, Thune JJ, et al. Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies: a 9-year follow-up study. Int J Cardiol 2015;182:403-11.   DOI
66 Ronvelia D, Greenwood J, Platt J, Hakim S, Zaragoza MV. Intrafamilial variability for novel TAZ gene mutation: barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle. Mol Genet Metab 2012;107:428-32.   DOI
67 Van Der Starre P, Deuse T, Pritts C, Brun C, Vogel H, Oyer P. Late profound muscle weakness following heart transplantation due to Danon disease. Muscle Nerve 2013;47:135-7.   DOI
68 Miani D, Taylor M, Mestroni L, et al. Sudden death associated with danon disease in women. Am J Cardiol 2012;109:406-11.   DOI
69 Oliveira J, Negrao L, Fineza I, et al. New splicing mutation in the choline kinase beta (CHKB) gene causing a muscular dystrophy detected by whole-exome sequencing. J Hum Genet 2015;60:305-12.   DOI
70 Dittrich S, Tuerk M, Haaker G, et al. Cardiomyopathy in duchenne muscular dystrophy: current value of clinical, electrophysiological and imaging findings in children and teenagers. Klin Padiatr 2015;227:225-231.   DOI
71 Dec GW. Steroid therapy effectively delays Duchenne's cardiomyopathy. J Am Coll Cardiol 2013;61:955-6.   DOI
72 van Westering TL, Betts CA, Wood MJ. Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy. Molecules 2015;20:8823-55.   DOI
73 Wochna K, Jurczyk AP, Krajewski W, Berent J. Sudden death due to malignant hyperthermia during general anesthesia. Arch Med Sadowej Kryminol 2013;63:11-4, 7-10.
74 Finsterer J, Cripe L. Treatment of dystrophin cardiomyopathies. Nat Rev Cardiol 2014;11:168-79.   DOI
75 But WM, Lee SH, Chan AO, Lau GT. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation. Hong Kong Med J 2009;15:474-7.
76 Fujita K, Nakano S, Yamamoto H, Ito H, Ito H, Goto Y, Kusaka H. An adult case of congenital fiber type disproportion (CFTD) with cardiomyopathy. Rinsho Shinkeigaku 2005;45:380-2.
77 Kajino S, Ishihara K, Goto K, et al. Congenital fiber type disproportion myopathy caused by LMNA mutations. J Neurol Sci 2014;340:94-8.   DOI
78 Gatayama R, Ueno K, Nakamura H, et al. Nemaline myopathy with dilated cardiomyopathy in childhood. Pediatrics 2013;131:e1986-90.   DOI
79 Sarullo FM, Vitale G, Di Franco A, et al. Nemaline myopathy and heart failure: role of ivabradine; a case report. BMC Cardiovasc Disord 2015;15:5.   DOI
80 Mir A, Lemler M, Ramaciotti C, Blalock S, Ikemba C. Hypertrophic cardiomyopathy in a neonate associated with nemaline myopathy. Congenit Heart Dis 2012;7:E37-41.   DOI
81 Muller TJ, Kraya T, Stoltenburg-Didinger G, et al. Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 2014;76:669-80.   DOI
82 Naddaf E, Waclawik AJ. Two families with MYH7 distal myopathy associated with cardiomyopathy and core formations. J Clin Neuromuscul Dis 2015;16:164-9.   DOI
83 Lefter S, Hardiman O, McLaughlin RL, Murphy SM, Farrell M, Ryan AM. A novel MYH7 Leu1453pro mutation resulting in Laing distal myopathy in an Irish family. Neuromuscul Disord 2015;25:155-60.   DOI
84 Finsterer J, Stollberger C, Brandau O, Laccone F, Bichler K, Laing NG. Novel MYH7 mutation associated with mild myopathy but life-threatening ventricular arrhythmias and noncompaction. Int J Cardiol 2014;173:532-5.   DOI
85 Gossios TD, Lopes LR, Elliott PM. Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1. Eur J Med Genet 2013;56:251-5.   DOI
86 van den Bergen JC, Schade van Westrum SM, Dekker L, et al. Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy. J Neurol Neurosurg Psychiatry 2014;85:92-8.   DOI
87 Finsterer J, Stollberger C, Sehnal E, Rehder H, Laccone F. Dilated, arrhythmogenic cardiomyopathy in emery-dreifuss muscular dystrophy due to the emerin splice-site mutation c.449 + 1G>A. Cardiology 2015;130:48-51.   DOI
88 Pen AE, Nyegaard M, Fang M, et al. A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology. Eur J Med Genet 2015;58:222-9.   DOI
89 Tiffin HR, Jenkins ZA, Gray MJ, et al. Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype. Neurogenetics 2013;14:113-21.   DOI
90 Wessely R, Seidl S, Schomig A. Cardiac involvement in Emery-Dreifuss muscular dystrophy. Clin Genet 2005;67:220-3.   DOI
91 Coutance G, Labombarda F, Cauderlier E, et al. Hypoplasia of the aorta in a patient diagnosed with LMNA gene mutation. Congenit Heart Dis 2013;8:E127-9.   DOI
92 Redondo-Verge L, Yaou RB, Fernandez-Recio M, Dinca L, Richard P, Bonne G. Cardioembolic stroke prompting diagnosis of LMNA-associated Emery-Dreifuss muscular dystrophy. Muscle Nerve 2011;44:587-9.   DOI
93 Maggi L, D'Amico A, Pini A, et al. LMNA-associated myopathies: the Italian experience in a large cohort of patients. Neurology 2014;83:1634-44.   DOI
94 Sveen ML, Thune JJ, Kober L, Vissing J. Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. Arch Neurol 2008;65:1196-201.
95 D'Arcy C, Kanellakis V, Forbes R, et al. X-linked recessive distal myopathy with hypertrophic cardiomyopathy caused by a novel mutation in the FHL1 gene. J Child Neurol 2015;30:1211-7.   DOI
96 Authors/Task Force members, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-79.   DOI
97 Prater SN, Banugaria SG, DeArmey SM, et al. The emerging phenotype of long-term survivors with infantile Pompe disease. Genet Med 2012;14:800-10.   DOI
98 Yoda M, Tanabe H, Nishino I, Suma H. Left ventriculoplasty for dilated cardiomyopathy in Fukuyama-type muscular dystrophy. Eur J Cardiothorac Surg 2011;40:514-6.
99 Jefferies JL, Wilkinson JD, Sleeper LA, et al. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: results from the pediatric cardiomyopathy registry. J Card Fail 2015;21:877-84.   DOI
100 Gdynia HJ, Kurt A, Endruhn S, Ludolph AC, Sperfeld AD. Cardiomyopathy in motor neuron diseases. J Neurol Neurosurg Psychiatry 2006;77:671-3.   DOI
101 Hattori T, Ikeda S, Yoshida K, Yanagisawa N, Furihata K, Yoshida K. A patient with Kennedy-Alter-Sung syndrome showing cardiomyopathy. Rinsho Shinkeigaku 1995;35:1246-9.
102 Al-Thihli K, Ebrahim H, Hughes DA, et al. A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy. Gene 2012;497:320-2.   DOI
103 Nussinovitch U, Katz U, Nussinovitch M, Nussinovitch N. Beat-to-beat QT interval dynamics and variability in familial dysautonomia. Pediatr Cardiol 2010;31:80-4.   DOI
104 Ergul Y, Ekici B, Keskin S. Cardiac arrest after anesthetic management in a patient with hereditary sensory autonomic neuropathy type IV. Saudi J Anaesth 2011;5:93-5.   DOI
105 Losito L, De Rinaldis M, Gennaro L, et al. Charcot-Marie-Tooth type 1a in a child with Long QT syndrome. Eur J Paediatr Neurol 2009;13:459-62.   DOI
106 Kayman-Kurekci G, Talim B, Korkusuz P, et al. Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies. Neuromuscul Disord 2014;24:624-33.   DOI
107 Nalini A, Gayathri N, Richard P, Cobo AM, Urtizberea JA. New mutation of the desmin gene identified in an extended Indian pedigree presenting with distal myopathy and cardiac disease. Neurol India 2013;61:622-6.   DOI
108 Nishino I, Noguchi S, Murayama K, et al. Molecular pathomechanism of distal myopathy with rimmed vacuoles. Rinsho Shinkeigaku 2005;45:943-5.
109 Volpi L, Ricci G, Passino C, et al. Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication. Neuromuscul Disord 2010;20:512-6.   DOI
110 Groh WJ. Arrhythmias in the muscular dystrophies. Heart Rhythm 2012;9:1890-5.   DOI
111 Quick S, Schaefer J, Waessnig N, et al. Evaluation of heart involvement in calpainopathy (LGMD2A) using cardiovascular magnetic resonance. Muscle Nerve 2015;52:661-3.   DOI
112 Okere A, Reddy SS, Gupta S, Shinnar M. A cardiomyopathy in a patient with limb girdle muscular dystrophy type 2A. Circ Heart Fail 2013;6:e12-3.   DOI
113 Nishikawa A, Mori-Yoshimura M, Segawa K, et al. Respiratory and cardiac function in Japanese patients with dysferlinopathy. Muscle Nerve 2015. [Epub ahead of print]
114 Ishiwata S, Nishiyama S, Seki A, Kojima S. Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles. Jpn Circ J 1993;57:928-33.   DOI
115 Kimpara T, Imamura T, Tsuda T, Sato K, Tsuburaya K. Distal myopathy with rimmed vacuoles and sudden death--report of two siblings. Rinsho Shinkeigaku 1993;33:886-90.
116 Krendel DA, Gilchrist JM, Bossen EH. Distal vacuolar myopathy with complete heart block. Arch Neurol 1988;45:698-9.   DOI
117 Maffe S, Signorotti F, Perucca A, et al. Atypical arrhythmic complications in familial hypokalemic periodic paralysis. J Cardiovasc Med (Hagerstown) 2009;10:68-71.   DOI
118 Green DS, Hayward LJ, George AL Jr, Cannon SC. A proposed mutation, Val781Ile, associated with hyperkalemic periodic paralysis and cardiac dysrhythmia is a benign polymorphism. Ann Neurol 1997;42:253-6.   DOI
119 Stunnenberg BC, Deinum J, Links TP, Wilde AA, Franssen H, Drost G. Cardiac arrhythmias in hypokalemic periodic paralysis: Hypokalemia as only cause? Muscle Nerve 2014;50:327-32.   DOI
120 Caballero PE. Becker myotonia congenita associated with Wolff-Parkinson-White syndrome. Neurologist 2011;17:38-40.   DOI
121 Rosales XQ, Moser SJ, Tran T, et al. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I. J Cardiovasc Magn Reson 2011;13:39.   DOI
122 Takahashi T, Aoki M, Suzuki N, et al. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B. J Neurol Neurosurg Psychiatry 2013;84:433-40.   DOI
123 Kuru S, Yasuma F, Wakayama T, et al. A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy. Rinsho Shinkeigaku 2004;44:375-8.
124 Calvo F, Teijeira S, Fernandez JM, et al. Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients. Neuromuscul Disord 2000;10:560-6.   DOI
125 Merlini L, Kaplan JC, Navarro C, et al. Homogeneous phenotype of the gypsy limb-girdle MD with the gamma-sarcoglycan C283Y mutation. Neurology 2000;54:1075-9.   DOI
126 Semplicini C, Vissing J, Dahlqvist JR, et al. Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E. Neurology 2015;84:1772-81.   DOI
127 Millaire A, Warembourg A, Leys D, et al. Refsum's disease. Apropos of 2 cases disclosed by myocardiopathy. Ann Cardiol Angeiol (Paris) 1990;39:173-8.
128 Nakagawa H, Okayama S, Kamon D, et al. Refractory high output heart failure in a patient with primary mitochondrial respiratory chain disease. Intern Med 2014;53:315-9.   DOI
129 Palecek T, Tesarova M, Kuchynka P, et al. Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m.3303C>T diagnosed in an adult male. Int Heart J 2012;53:383-7.   DOI
130 Barisic N, Kleiner IM, Malcic I, Papa J, Boranic M. Spinal dysraphism associated with congenital heart disorder in a girl with MELAS syndrome and point mutation at mitochondrial DNA nucleotide 3271. Croat Med J 2002;43:37-41.
131 Barragan-Campos HM, Barrera-Ramirez CF, Iturralde Torres P, et al. Kearns-Sayre syndromes an absolute indication for prophylactic implantation of definitive pacemaker? Arch Inst Cardiol Mex 1999;69:559-65.
132 Benhayon D, Lugo R, Patel R, Carballeira L, Elman L, Cooper JM. Long-term arrhythmia follow-up of patients with myotonic dystrophy. J Cardiovasc Electrophysiol 2015;26:305-10.   DOI
133 Brembilla-Perrot B, Schwartz J, Huttin O, et al. Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy. Pacing Clin Electrophysiol 2014;37:329-35.   DOI
134 Pambrun T, Bortone A, Bois P, et al. Unmasked Brugada pattern by ajmaline challenge in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol 2015;20:28-36.   DOI
135 Russo V, Di Meo F, Rago A, et al. Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. Eur Rev Med Pharmacol Sci 2015;19:1241-8.
136 Finsterer J, Stollberger C, Gencik M, Hoftberger R, Rahimi J, Mokocki J. Syncope and hyperCKemia as minimal manifestations of short CTG repeat expansions in myotonic dystrophy type 1. Rev Port Cardiol 2015;34:361.e1-4.
137 Finsterer J, Rudnik-Schoneborn S. Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy. Fortschr Neurol Psychiatr 2015;83:9-17.   DOI
138 Kilic T, Vural A, Ural D, et al. Cardiac resynchronization therapy in a case of myotonic dystrophy (Steinert's disease) and dilated cardiomyopathy. Pacing Clin Electrophysiol 2007;30:916-20.   DOI
139 Finsterer J, Stolberger C, Kopsa W. Noncompaction in myotonic dystrophy type 1 on cardiac MRI. Cardiology 2005;103:167-8.   DOI
140 Petri H, Ahtarovski KA, Vejlstrup N, et al. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014;16:59.   DOI
141 Watanabe Y, Odaka M, Hirata K. Case of Leber's hereditary optic neuropathy with mitochondrial DNA 11778 mutation exhibiting cerebellar ataxia, dilated cardiomyopathy and peripheral neuropathy. Brain Nerve 2009;61:309-12.
142 Aimo A, Giannoni A, Piepoli MF, et al. Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance. Int J Cardiol 2014;176:1396-8.   DOI
143 Brecht M, Richardson M, Taranath A, Grist S, Thorburn D, Bratkovic D. Leigh syndrome daused by the MT-ND5 m.13513G>A mutation: a case presenting with WPW-like conduction defect, cardiomyopathy, hypertension and hyponatraemia. JIMD Rep 2015;19:95-100.
144 Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010;12:114-21.   DOI
145 Florian A, Ludwig A, Stubbe-Drager B, et al. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy. J Cardiovasc Magn Reson 2015;17:40.   DOI
146 Brea-Calvo G, Haack TB, Karall D, et al. COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency. Am J Hum Genet 2015;96:309-17.   DOI
147 Fanin M, Melacini P, Boito C, Pegoraro E, Angelini C. LGMD2E patients risk developing dilated cardiomyopathy. Neuromuscul Disord 2003;13:303-9.   DOI
148 Wahbi K, Meune C, Hamouda el H, et al. Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromuscul Disord 2008;18:650-5.   DOI
149 Hollingsworth KG, Willis TA, Bates MG, et al. Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I. Eur J Heart Fail 2013;15:986-94.   DOI
150 Gaul C, Deschauer M, Tempelmann C, et al. Cardiac involvement in limb-girdle muscular dystrophy 2I: conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 2006;253:1317-22.   DOI
151 D'Amico A, Petrini S, Parisi F, et al. Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy. Neuromuscul Disord 2008;18:153-5.   DOI
152 Schottlaender LV, Petzold A, Wood N, Houlden H. Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limb-girdle muscular dystrophy. J Neurol Sci 2015;348:266-8.   DOI
153 Matsui M, Endo T, Matsumura T, Saito T, Fujimura H. A case of limb-girdle muscular dystrophy 2M diagnosed by the occurence of dilated cardiomyopathy. Rinsho Shinkeigaku 2015;55-585-8.   DOI
154 Schade van Westrum SM, Dekker LR, de Voogt WG, et al. Cardiac involvement in Dutch patients with sarcoglycanopathy: a cross-sectional cohort and follow-up study. Muscle Nerve 2014;50:909-13.   DOI
155 Dincer P, Bonnemann CG, Erdir Aker O, et al. A homozygous nonsense mutation in delta-sarcoglycan exon 3 in a case of LGMD2F. Neuromuscul Disord 2000;10:247-50.   DOI
156 Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000;106:655-62.   DOI
157 Petri H, Witting N, Ersboll MK, et al. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study. Int J Cardiol 2014;174:31-6.   DOI
158 Hertzman PA, Maddoux GL, Sternberg EM, et al. Repeated coronary artery spasm in a young woman with the eosinophilia-myalgia syndrome. JAMA 1992;267:2932-4.   DOI
159 Rubin HJ, Lowbeer L. Progressive muscular dystrophy with involvement of heart muscle. Proc Staff Meet Tulsa Okla Hillcrest Meml Hosp 1947;4:141-56.
160 Coelho E. Heart changes in the familial type of paramyloidosis with peripheral neuropathy. Z Kreislaufforsch 1963;52:1066-78.
161 Rakocevic-Stojanovic V, Pavlovic S, Seferovic P, et al. Pathohistological changes in endomyocardial biopsy specimens in patients with myotonic dystrophy. Panminerva Med 1999;41:27-30.
162 Bu'Lock FA, Sood M, De Giovanni JV, Green SH. Left ventricular diastolic function in congenital myotonic dystrophy. Arch Dis Child 1999;80:267-70.   DOI
163 Viitasalo MT, Kala R, Karli P, Eisalo A. Ambulatory electrocardiographic recording in mild or moderate myotonic dystrophy and myotonia congenita (Thomsen's disease). J Neurol Sci 1983;62:181-90.   DOI
164 Kim HN, Cho YK, Cho JH, Yang EM, Song ES, Choi YY. Transient complete atrioventricular block in a preterm neonate with congenital myotonic dystrophy: case report. J Korean Med Sci 2014;29:879-83.   DOI
165 Kopajtich R, Nicholls TJ, Rorbach J, et al. Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy. Am J Hum Genet 2014;95:708-20.   DOI
166 Palladino A, Passamano L, Taglia A, et al. Cardiac involvement in patients with spinal muscular atrophies. Acta Myol 2011;30:175-8.
167 Yasuma F, Kuru S, Konagaya M. Dilated cardiomyopathy in Kugelberg-Welander disease: coexisting sleep disordered breathing and its treatment with continuous positive airway pressure. Intern Med 2004;43:951-4.   DOI
168 Elkohen M, Vaksmann G, Elkohen MR, Francart C, Foucher C, Rey C. Cardiac involvement in Kugelberg-Welander disease. A prospective study of 8 cases. Arch Mal Coeur Vaiss 1996;89:611-7.
169 Distelmaier F, Haack TB, Catarino CB, et al. MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic cardiomyopathy. Neurogenetics 2015;16:319-23.   DOI
170 Brisca G, Fiorillo C, Nesti C, et al. Early onset cardiomyopathy associated with the mitochondrial tRNALeu((UUR)) 3271T>C MELAS mutation. Biochem Biophys Res Commun 2015;458:601-4.   DOI
171 Wortmann SB, Champion MP, van den Heuvel L, et al. Mitochondrial DNA m.3242G > A mutation, an under diagnosed cause of hypertrophic cardiomyopathy and renal tubular dysfunction? Eur J Med Genet 2012;55:552-6.   DOI
172 Wang SB, Weng WC, Lee NC, Hwu WL, Fan PC, Lee WT. Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy. Pediatr Neonatol 2008;49:145-9.   DOI
173 Menotti F, Brega A, Diegoli M, Grasso M, Modena MG, Arbustini E. A novel mtDNA point mutation in tRNA(Val) is associated with hypertrophic cardiomyopathy and MELAS. Ital Heart J 2004;5:460-5.
174 Homan DJ, Niyazov DM, Fisher PW, et al. Heart transplantation for a patient with Kearns-Sayre syndrome and end-stage heart failure. Congest Heart Fail 2011;17:102-4.
175 Malfatti E, Laforet P, Jardel C, et al. High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology 2013;80:100-5.   DOI
176 Della Marca G, Frusciante R, Scatena M, et al. Heart rate variability in facioscapulohumeral muscular dystrophy. Funct Neurol 2010;25:211-6.
177 Finsterer J, Stollberger C, Gatterer E, Jakubiczka S. Intermittent pre-excitation-syndrome in facio-scapulo-humeral muscular dystrophy. Korean Circ J 2014;44:348-50.   DOI
178 Nakayama T, Komiya T, Tyou E, Watanabe S, Kawai M. Cardiac deformity and dysfunction in facioscapulohumeral dystrophy--electrocardiogram, ECG gate cardiac MRI studies. Rinsho Shinkeigaku 1999;39:610-4.
179 Faustmann PM, Farahati J, Rupilius B, Dux R, Koch MC, Reiners C. Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 single-photon-emission-computed tomography. J Neurol Sci 1996;144:59-63.   DOI
180 Pasqualin LM, Reed UC, Costa TV, et al. Congenital muscular dystrophy with dropped head linked to the LMNA gene in a Brazilian cohort. Pediatr Neurol 2014;50:400-6.   DOI
181 Flock A, Kornblum C, Hammerstingl C, Claeys KG, Gembruch U, Merz WM. Progressive cardiac dysfunction in Bethlem myopathy during pregnancy. Obstet Gynecol 2014;123(2 Pt 2 Suppl 2):436-8.   DOI
182 Rudnik-Schoneborn S, Schaupp M, Lindner A, et al. Brugada-like cardiac disease in myotonic dystrophy type 2: report of two unrelated patients. Eur J Neurol 2011;18:191-4.   DOI
183 Lee TM, Maurer MS, Karbassi I, Braastad C, Batish SD, Chung WK. Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9. Congest Heart Fail 2012;18:183-6.   DOI
184 Wahbi K, Meune C, Bassez G, et al. Left ventricular non-compaction in a patient with myotonic dystrophy type 2. Neuromuscul Disord 2008;18:331-3.   DOI
185 Brunetti-Pierri N, Pignatelli R, Fouladi N, et al. Dilation of the aortic root in mitochondrial disease patients. Mol Genet Metab 2011;103:167-70.   DOI
186 Finsterer J. Is atherosclerosis a mitochondrial disorder? Vasa 2007;36:229-40.   DOI
187 Dominic EA, Ramezani A, Anker SD, Verma M, Mehta N, Rao M. Mitochondrial cytopathies and cardiovascular disease. Heart 2014;100:611-8.   DOI
188 Yajima N, Yazaki Y, Yoshida K, et al. A case of mitochondrial cardiomyopathy with pericardial effusion evaluated by (99m)Tc-MIBI myocardial scintigraphy. J Nucl Cardiol 2009;16:989-94.   DOI
189 Iwahara N, Hisahara S, Hayashi T, Kawamata J, Shimohama S. A novel lamin A/C gene mutation causing spinal muscular atrophy phenotype with cardiac involvement: report of one case. BMC Neurol 2015;15:13.   DOI
190 Finsterer J, Stollberger C, Sehnal E, Valentin A, Huber J, Schmiedel J. Apical ballooning (Takotsubo syndrome) in mitochondrial disorder during mechanical ventilation. J Cardiovasc Med (Hagerstown) 2007;8:859-63.   DOI
191 Plonka C, Wearden PD, Morell VO, Miller SA, Webber SA, Feingold B. Successful heart transplantation from a donor with Ullrich congenital muscular dystrophy. Am J Transplant 2013;13:1915-7.   DOI
192 Martinez HR, Craigen WJ, Ummat M, Adesina AM, Lotze TE, Jefferies JL. Novel cardiovascular findings in association with a POMT2 mutation: three siblings with ${\alpha}$-dystroglycanopathy. Eur J Hum Genet 2014;22:486-91.   DOI
193 Haliloglu G, Talim B, Sel CG, Topaloglu H. Clinical characteristics of megaconial congenital muscular dystrophy due to choline kinase beta gene defects in a series of 15 patients. J Inherit Metab Dis 2015;38:1099-108.   DOI